These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

288 related items for PubMed ID: 12771801

  • 1. Association of V89L SRD5A2 polymorphism with prostate cancer development in a Japanese population.
    Li Z, Habuchi T, Mitsumori K, Kamoto T, Kinoshitu H, Segawa T, Ogawa O, Kato T.
    J Urol; 2003 Jun; 169(6):2378-81. PubMed ID: 12771801
    [Abstract] [Full Text] [Related]

  • 2. Polymorphic markers in the SRD5A2 gene and prostate cancer risk: a population-based case-control study.
    Hsing AW, Chen C, Chokkalingam AP, Gao YT, Dightman DA, Nguyen HT, Deng J, Cheng J, Sesterhenn IA, Mostofi FK, Stanczyk FZ, Reichardt JK.
    Cancer Epidemiol Biomarkers Prev; 2001 Oct; 10(10):1077-82. PubMed ID: 11588134
    [Abstract] [Full Text] [Related]

  • 3. Associations between polymorphisms in the steroid 5-alpha reductase type II (SRD5A2) gene and benign prostatic hyperplasia and prostate cancer.
    Salam MT, Ursin G, Skinner EC, Dessissa T, Reichardt JK.
    Urol Oncol; 2005 Oct; 23(4):246-53. PubMed ID: 16018939
    [Abstract] [Full Text] [Related]

  • 4. [Association of polymorphisms in testosterone 5-alpha-reductase II genotype and prognosis factors of prostate cancer].
    Tong M, Xu Z, Ai JK, Yuan YM, Yin Y, Wang JQ, Li HW, Liu JH, Xin DQ, Zhou LQ, Li M, Na YQ.
    Zhonghua Wai Ke Za Zhi; 2004 Dec 22; 42(24):1493-6. PubMed ID: 15733480
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of SRD5A2 sequence variants in susceptibility to hereditary and sporadic prostate cancer.
    Chang BL, Zheng SL, Isaacs SD, Turner AR, Bleecker ER, Walsh PC, Meyers DA, Isaacs WB, Xu J.
    Prostate; 2003 Jun 15; 56(1):37-44. PubMed ID: 12746845
    [Abstract] [Full Text] [Related]

  • 6. Association among polymorphisms in the steroid 5alpha-reductase type II (SRD5A2) gene, prostate cancer risk, and pathologic characteristics of prostate tumors in an Ecuadorian population.
    Paz-y-Miño C, Witte T, Robles P, Llumipanta W, Díaz M, Arévalo M.
    Cancer Genet Cytogenet; 2009 Mar 15; 189(2):71-6. PubMed ID: 19215786
    [Abstract] [Full Text] [Related]

  • 7. The V89L polymorphism in the 5-alpha-reductase type 2 gene and risk of breast cancer.
    van Gils CH, Onland-Moret NC, Roest M, van Noord PA, Peeters PH.
    Cancer Epidemiol Biomarkers Prev; 2003 Nov 15; 12(11 Pt 1):1194-9. PubMed ID: 14652280
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Longer (TA)n repeat but not A49T and V89L polymorphisms in SRD5A2 gene may confer prostate cancer risk in South Indian men.
    Rajender S, Vijayalakshmi K, Pooja S, Madhavi S, Paul SF, Vettriselvi V, Shroff S, Singh L, Thangaraj K.
    J Androl; 2009 Nov 15; 30(6):703-10. PubMed ID: 19443907
    [Abstract] [Full Text] [Related]

  • 10. [Association between A49T polymorphism of SRD5A2 gene and risk of prostate cancer].
    Tong M, Ai JK, Yuan YM, Yin Y, Zhou LQ, Xin DQ, Li M, Na YQ.
    Zhonghua Yi Xue Za Zhi; 2005 May 25; 85(19):1319-21. PubMed ID: 16029630
    [Abstract] [Full Text] [Related]

  • 11. Polymorphisms in the androgen receptor and type II 5 alpha-reductase genes and prostate cancer prognosis.
    Shibata A, Garcia MI, Cheng I, Stamey TA, McNeal JE, Brooks JD, Henderson S, Yemoto CE, Peehl DM.
    Prostate; 2002 Sep 01; 52(4):269-78. PubMed ID: 12210487
    [Abstract] [Full Text] [Related]

  • 12. Association of vitamin D receptor gene polymorphism with prostate cancer and benign prostatic hyperplasia in a Japanese population.
    Habuchi T, Suzuki T, Sasaki R, Wang L, Sato K, Satoh S, Akao T, Tsuchiya N, Shimoda N, Wada Y, Koizumi A, Chihara J, Ogawa O, Kato T.
    Cancer Res; 2000 Jan 15; 60(2):305-8. PubMed ID: 10667581
    [Abstract] [Full Text] [Related]

  • 13. [V89L polymorphism of the testosterone 5-alpha-reductase II gene and prognostic factors of prostate cancer].
    Tong M, Jin YY, Li G, Liu SM, Ji CD.
    Zhonghua Nan Ke Xue; 2010 Nov 15; 16(11):990-3. PubMed ID: 21218640
    [Abstract] [Full Text] [Related]

  • 14. Polymorphisms in the 5alpha reductase type 2 gene and urologic measures of BPH.
    Roberts RO, Bergstralh EJ, Farmer SA, Jacobson DJ, McGree ME, Hebbring SJ, Cunningham JM, Anderson SA, Thibodeau SN, Lieber MM, Jacobsen SJ.
    Prostate; 2005 Mar 01; 62(4):380-7. PubMed ID: 15389785
    [Abstract] [Full Text] [Related]

  • 15. V89L polymorphism of the 5alpha-reductase Type II gene (SRD5A2), endogenous sex hormones, and prostate cancer risk.
    Boger-Megiddo I, Weiss NS, Barnett MJ, Goodman GE, Chen C.
    Cancer Epidemiol Biomarkers Prev; 2008 Feb 01; 17(2):286-91. PubMed ID: 18268111
    [Abstract] [Full Text] [Related]

  • 16. SRD5A2 V89L polymorphism and prostate cancer risk: a meta-analysis.
    Wang C, Tao W, Chen Q, Hu H, Wen XY, Han R.
    Prostate; 2010 Feb 01; 70(2):170-8. PubMed ID: 19760631
    [Abstract] [Full Text] [Related]

  • 17. Insulin-like growth factor-binding protein-3 gene -202 A/C polymorphism is correlated with advanced disease status in prostate cancer.
    Wang L, Habuchi T, Tsuchiya N, Mitsumori K, Ohyama C, Sato K, Kinoshita H, Kamoto T, Nakamura A, Ogawa O, Kato T.
    Cancer Res; 2003 Aug 01; 63(15):4407-11. PubMed ID: 12907612
    [Abstract] [Full Text] [Related]

  • 18. Association of polymorphisms within androgen receptor, 5alpha-reductase, and PSA genes with prostate volume, clinical parameters, and endocrine status in elderly men.
    Schatzl G, Madersbacher S, Gsur A, Preyer M, Haidinger G, Haitel A, Vutuc C, Micksche M, Marberger M.
    Prostate; 2002 Jul 01; 52(2):130-8. PubMed ID: 12111704
    [Abstract] [Full Text] [Related]

  • 19. Catechol-O-methyltransferase gene polymorphisms in benign prostatic hyperplasia and sporadic prostate cancer.
    Tanaka Y, Sasaki M, Shiina H, Tokizane T, Deguchi M, Hirata H, Hinoda Y, Okayama N, Suehiro Y, Urakami S, Kawakami T, Kaneuchi M, Pookot D, Igawa M, Okuyama A, Ishii N, Dahiya R.
    Cancer Epidemiol Biomarkers Prev; 2006 Feb 01; 15(2):238-44. PubMed ID: 16492910
    [Abstract] [Full Text] [Related]

  • 20. [Genetic risk factors of prostate cancer in Han nationality population in Northern China and a preliminary study of the reason of racial difference in prevalence of prostate cancer].
    Liu JH, Li HW, Tong M, Li M, Na YQ.
    Zhonghua Yi Xue Za Zhi; 2004 Mar 02; 84(5):364-8. PubMed ID: 15061984
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.